Gary Stone, a well respected technical analyst, has a buy on this stock, as mentioned on the switzerland program last week... Target of around a dollar short term I think.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025